Links

Tools

Export citation

Search in Google Scholar

A FcgammaRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy.

Journal article published in 2014 by Marc Turini, Patrick Chames, Pierre Bruhns ORCID, Daniel Baty, Brigitte Kerfelec
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload